Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.

Matarin M., Salih D.A., Yasvoina M., Cummings D.M., Guelfi S., Liu W., Nahaboo Solim M.A., Moens T.G., Paublete R.M., Ali S.S., Perona M., Desai R., Smith K.J., Latcham J., Fulleylove M., Richardson J.C., Hardy J., Edwards F.A.

We provide microarray data comparing genome-wide differential expression and pathology throughout life in four lines of "amyloid" transgenic mice (mutant human APP, PSEN1, or APP/PSEN1) and "TAU" transgenic mice (mutant human MAPT gene). Microarray data were validated by qPCR and by comparison to human studies, including genome-wide association study (GWAS) hits. Immune gene expression correlated tightly with plaques whereas synaptic genes correlated negatively with neurofibrillary tangles. Network analysis of immune gene modules revealed six hub genes in hippocampus of amyloid mice, four in common with cortex. The hippocampal network in TAU mice was similar except that Trem2 had hub status only in amyloid mice. The cortical network of TAU mice was entirely different with more hub genes and few in common with the other networks, suggesting reasons for specificity of cortical dysfunction in FTDP17. This Resource opens up many areas for investigation. All data are available and searchable at

Cell Rep 10:633-644(2015) [PubMed] [Europe PMC]

UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again